ResMed’s first quarter results were met with a strong market response, reflecting in-line revenue and profit performance alongside notable margin expansion. Management credited manufacturing and ...

These stocks were in great health last financial year. The post These 5 ASX 200 healthcare shares gained the most weight in ...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? One ...

ResMed is taking a “smart devices” and Big Data approach to further entrench itself as one of the two leading players in the global obstructive sleep apnea, or OSA, market.

ResMed (RMD) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- ...

Shares of ResMed Inc. RMD rallied 1.11% to $258.00 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.52% to 6,204.95 and the ...

The stocks in this week’s article are Sprouts Farmers Market SFM, Adobe ADBE, GE Aerospace GE and ResMed RMD. Scoop Up These ...

UBS is bullish and has a buy rating and $215.00 price target on its shares.